The heterocycles containing benzopyrimidine moiety has a variety of biological activities such as analgesic, antiinflammatory and antimicrobial activities (Moneam et al., 2004 and Bodke et al., 2003). As part of our studies of these systems (Puttaraju et al., 2013), the title compound was prepared and characterized by single-crystal X-ray diffraction.
In the title compound, C 25 H 14 F 3 N 3 O 3 , the dihedral angle between the planes of the benz [4, 5] imidazo[1,2-a]pyrimidine unit (r.m.s. deviation = 0.035 Å ) and the benzochromene ring system (r.m.s. deviation = 0.106 Å ) is 72.82 (5) . In the crystal, molecules are linked by C-HÁ Á ÁO interactions, generating [010] C(9) chains. A weak aromaticstacking interaction [centroid-centroid separation = 3.5376 (15) Å ] is also observed. Keywords: crystal structure; fused-ring system; chromene; benzimidazole; pyrimidinone; benzopyrimidine;stacking interactions.
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Related literature
For background to benzopyrimidine derivatives, see: Bodke et al. (2003) ; Moneam et al. (2004) . For the synthesis of the title compound, see: Puttaraju et al. (2013) . For a related structure, see: Chandra et al. (2013) 
Refinement
R[F 2 > 2(F 2 )] = 0.057 wR(F 2 ) = 0.176 S = 1.00 5020 reflections 308 parameters H-atom parameters constrained Á max = 0.21 e Å À3 Á min = À0.19 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Symmetry code: (i) Àx þ 1 2 ; y þ 1 2 ; Àz þ 1 2 .
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT (Bruker, 2009); data reduction: SAINT ; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: PLATON (Spek, 2009); software used to prepare material for publication: SHELXL97.
Figure 1
Perspective diagram of the molecule with 50% probability displacement ellipsoids.
Figure 2
Packing diagram of the molecule viewed down the b axis. 
Refinement
Refinement on F 2 Least-squares matrix: full R[F 2 > 2σ(F 2 )] = 0.057 wR(F 2 ) = 0.176 S = 1.00 5020 reflections 308 parameters 0 restraints Primary atom site location: structure-invariant direct methods Secondary atom site location: difference Fourier map Hydrogen site location: inferred from neighbouring sites H-atom parameters constrained w = 1/[σ 2 (F o 2 ) + (0.0676P) 2 ]
where P = (F o 2 + 2F c 2 )/3 (Δ/σ) max < 0.001 Δρ max = 0.21 e Å −3 Δρ min = −0.19 e Å −3 Extinction correction: SHELXL, FC * =KFC[1+0.001XFC 2 Λ 3 /SIN(2Θ)] -1/4 Extinction coefficient: 0.0030 (8)
Special details
Geometry. Bond distances, angles etc. have been calculated using the rounded fractional coordinates. All su's are estimated from the variances of the (full) variance-covariance matrix. The cell e.s.d.'s are taken into account in the estimation of distances, angles and torsion angles Refinement. Refinement on F 2 for ALL reflections except those flagged by the user for potential systematic errors. Weighted R-factors wR and all goodnesses of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The observed criterion of F 2 > σ(F 2 ) is used only for calculating -R-factor-obs etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq F16 −0.06281 (18) 
